Neocardia LLC
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Neocardia LLC
Guidant: The New Rules of the Device Game
As it seeks to capitalize on new opportunities in both its CRM and interventional businesses, Guidant also confronts a device industry whose rules are changing. The second of a two-part series.
Market Pressure, Part II: Devices Cool Down
The boom times are over in devices. Now venture capitalists vow to focus more on business fundamentals. Entrepreneurs say the same, while they increasingly seek start-up money from private investors known as angels.
Guidant's Start-Up Mentality
Over the past four years, Guidant has been one of the most impressive performers among a group of high-flying big-cap device giants. But even as it wrestles with the usual problems of managing large businesses, in its penchant for self-invention and relentless pursuit of new technology, Guidant behaves more like the collection of start-ups its once was.
Novoste: Proving the Exception
Novoste is out to show that the changing device world still has room, in the right market, for a small single-product company to succeed against larger competitors.
Company Information
- Industry
- Medical Devices
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice